Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
기업
60 results (top 60)
- 단계 미표기모집 중· Neuromyelitis Optica Spectrum Disorder임신 중 UPLIZNA®에 노출된 신경척수염 시신경염 스펙트럼 장애(NMOSD) 여성의 관찰 안전성 연구
Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy
리드: 암젠
- 3상모집 중· Small Cell Lung Cancer광범위 병기 소세포폐암에서 타를라타맙(피하 vs 정맥)의 3상 시험
Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
리드: 암젠
- 3상모집 중· Primary Immune Thrombocytopenia미치료 일차 면역성 혈소판 감소증 치료를 위한 로미플로스팀 플러스 프레드니소론 대 프레드니소론 단독 연구
A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)
리드: 암젠
- 1상모집 중· Healthy Participants건강한 중국 및 일본 자원자에서 AMG 691의 1단계 임상시험
A Phase 1 Trial of AMG 691 in Healthy Chinese and Japanese Volunteers
리드: 암젠
- 3상모집 중· Obesity마리데바르트 카프라글루티드의 장기 효능, 안전성 및 내약성을 평가하는 확장 시험 (MARITIME-2-EXTENSION)
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
리드: 암젠
- 3상모집 중· Obesity마리드바르트 카프라글루타이드의 장기 유효성, 안전성 및 내약성 평가 확대 시험(MARITIME-1-EXTENSION)
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
리드: 암젠
- 2상모집 중· Generalized Myasthenia Gravis소아 일반화 근무력증 환자에서 이네빌리주맙의 약동학, 약력학, 안전성 및 내약성 평가 연구
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
리드: 암젠
- 1상모집 중· Diabetes Mellitus, Type 2건강한 참여자 및 2형 당뇨병 환자에서 AMG 127을 평가하는 임상시험
A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus
리드: 암젠
- 3상모집 중· Neovascular Age-related Macular Degeneration신생혈관 나이 관련 황반변성 환자에서 ABP 938 8mg 대 아플리버셉트의 효능, 안전성 및 면역원성 평가 연구
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
리드: 암젠
- 2/3상모집 중· Granulomatosis With Polyangiitis육아종증 다발혈관염의 이비인후과 증상에 대한 TAVNEOS
TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis
협력: 암젠
- 3상모집 중· Obesity or Overweight비만 또는 과체중 성인에서 GLP-1RA에서 마리데바르트 카프라글루타이드로의 전환(MARITIME-SWITCH)
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
리드: 암젠
- 2상모집 중· Thyroid Eye Disease갑상선 안구 질환이 있는 참가자에서 AMG 732의 효과 및 안전성을 평가하는 공개 롤오버 시험
An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease
리드: 암젠
- 1상모집 중· Metastatic Castration-resistant Prostate Cancer (mCRPC)전이성 거세 저항성 전립선암에서의 잘루리타미그 임상시험
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
리드: 암젠
- 1상모집 중· Small Cell Lung Cancer소세포폐암에서 타르라타마브 + ZL-1310 ± 항-PD-L1 연구
Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
리드: 암젠
- 2상모집 중· Extensive Stage Lung Small Cell Cancer전처치 광범위 소세포폐암 및 ECOG 수행도 2인 환자에서의 타를라타맙 임상시험
A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2
협력: 암젠
- 1상모집 중· Metastatic or Locally Advanced Solid Tumors With Microsatellite Instability-high (MSI-H) or Mismatched Repair Deficiency (dMMR)AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
리드: 암젠
- 3상모집 중· Cardiovascular DiseaseOlpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
리드: 암젠
- 2상모집 중· Extensive Stage Lung Small Cell CarcinomaTarlatamab for the Treatment of Extensive Stage Small-cell Lung Cancer
협력: 암젠
- 3상모집 중· Osteogenesis ImperfectaPediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis Imperfecta
리드: 암젠
- 2상모집 중· Overweight or Obesity and Elevated Liver FatA Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight
리드: 암젠
- 2상모집 중· Advanced Solid TumorsA Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation
리드: 암젠
- 2상모집 중· Extrapulmonary Small Cell Carcinoma and Neuroendocrine CarcinomaTarlatamab for Advanced Extrapulmonary Small Cell Carcinoma and Neuroendocrine Carcinoma (TAURUS)
협력: 암젠
- 3상모집 중· Metastatic Castration-resistant Prostate CancerA Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
리드: 암젠
- 1상모집 중· Metastatic Hormone-sensitive Prostate Cancer (mHSPC)Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
리드: 암젠
- 1상모집 중· Extensive Stage Small Cell Lung CancerA Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
리드: 암젠
- 1/2상모집 중· MelanomaRadiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
협력: 암젠
- 1상모집 중· KRAS Altered Advanced or Metastatic Solid TumorsAMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
리드: 암젠
- 3상모집 중· Atherosclerotic Cardiovascular DiseaseEvaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
리드: 암젠
- 2상모집 중· Systemic Lupus ErythematosusA Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
리드: 암젠
- 2상모집 중· Metastatic/Locally Advanced Small-Cell Lung CancerStudy Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocrine Carcinomas (NECs), With Biomarker Analysis to Characterize Response/Resistance (UNLOCK TARLATAMAB)
협력: 암젠
- 3상모집 중· Heart Failure With Preserved Ejection FractionMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
리드: 암젠
- 해당없음모집 중· Cardiovascular RiskImpact of the Corrie Lipids Digital Health Program on Lipid Optimization
협력: 암젠
- 3상모집 중· Chronic Obstructive Pulmonary Disease (COPD)A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
리드: 아스트라제네카 · 협력: 암젠
- 3상모집 중· Chronic Obstructive Pulmonary Disease (COPD)A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
리드: 아스트라제네카 · 협력: 암젠
- 3상모집 중· Sjögren's SyndromeA Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
리드: 암젠
- 2상모집 중· Acute Lymphoblastic LeukemiaTherapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
협력: 암젠, 화이자
- 1상모집 중· Extensive Stage Small Cell Lung CancerSubcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
리드: 암젠
- 4상모집 중· Antineutrophil Cytoplasmic Antibody-associated VasculitisA Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
리드: 암젠
- 1/2상모집 중· Lymphoblastic LeukemiaTINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
협력: 암젠
- 2상모집 중· Neuromyelitis Optica Spectrum DisorderStudy of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
리드: 암젠
- 2상모집 중· Multiple MyelomaStudy of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma
협력: 암젠, GSK
- 3상모집 중· Acute Lymphoblastic LeukemiaInterfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
협력: 암젠
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.